MyoD is a member of a family of DNAbinding transcription factors that contain a helix-loop-helix MyoD is a transcriptional activator that plays a principal role in muscle differentiation (11, 12) . It is one of a family of bHLH-containing muscle determination/differentiation factors that appear to function in vivo as heteromers with E2A gene products E12 and E47 (13, 14) . A 68-residue peptide containing the bHLH region of MyoD is sufficient for conversion of fibroblasts to myoblasts (15). The bHLH region of MyoD (MyoD-bHLH) forms dimers and tetramers in the absence of DNA (16) and binds DNA as a dimer (10).
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The oligomeric states of full-length myogenin, MyoD, and E12 have been assessed by using thin-zone sucrose-gradient sedimentation (17) . These studies demonstrate that in the absence of DNA both myogenin and MyoD reversibly form oligomers larger than dimer size and that E12 predominantly
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forms dimers. However, the reequilibration between oligomeric forms during the course of these experiments made it difficult to ascertain the stoichiometries.
To obtain direct evidence about the association behavior of MyoD? analytical ultracentrifugation experiments have been carried out on full-length MyoD, both alone and mixed with an HLH-containing peptide of E47 (E47-96). MyoD exhibits micellular behavior-i.e., highly cooperative and reversible selfassociation-forming asymmetric assemblies containing more than 100 monomers. Such behavior-could have significant implications for the function of MyoD. MATERIALS AND METHODS MyoD Preparation. Full-length MyoD and MyoD-bHLH were expressed and purified as described (16, 18) . The protein (1 mg) was size fractionated on a Superose 6 column by using a Pharmacia fast protein liquid chromatography (FPLC) system. TIhe column running buffer was 10% (vol/vol) glycerol/20 mM Hepes, pH 7.6/2 mM EDTA/p.1% Triton X-100/0.1 M NaCl/1 mM dithiothreitol/1 mM phenylmethylsulfonyl fluoride/2 ,ug each of pepstatin and leupeptin per ml. Fractions (0.2 ml) were collected, and aliquots were analyzed by a gel mobilityshift assay. Electrophoretic mobility-shift assays were performed essentially as described (18) (19) (20) by using 5% miniacrylamide gels. Purified protein was incubated for 5 min at room temperature in 20 mM Hepes, pH 7.6/50 mM KCl/3 mM MgCl2/1 mM EDTA/ 0.5% Nonidet P-40 with 500 ng of an oligonucleotide probe containing the muscle creatine kinase (MCK) (24) . Data were edited and analyzed as described (25) . Yielding z-average reduced molecular weights, oz (ref. 26 ; where orz-ci,oi2/ E Ciai, with ci the mass concentration and oi the reduced molecular weight of the ith component). Molecular weights (Mz) were calculated from a, by using a measured buffer density of 1.004 g/ml (23.3°C). Partial specific volumes (v) for MyoD (0.718 ml/g), MyoD-bHLH (0.725 ml/g), and E47-96 (0.731 ml/g) were calculated from their amino acid compositions and adjusted by -0.028 ml per gram of MyoD-bHLH E47-96 and -0.014 ml per gram of E47-96 to account for electrostriction effects (27, 28 ). An additional error of ±0.015 in v was included in calculating the confidence interval of Mz.
No charge correction was applied to the P of MyoD.
The critical micelle concentration (cmc) was estimated from the baseline-corrected A280 of the slowest boundary (<6 s) in sedimentation velocity experiments, using a calculated 6280 Of 0.48 ml mg-1 cm-1. The cmc determined in this fashion should be considered a low estimate since dissolution of the micelles at faster boundaries will contribute to the absorbance in the slower boundary.
Sedimentation velocity was conducted using a four-hole titanium rotor at 10,000, 20,000, 48,000, and 60,000 rpm and at a constant temperature of 20.0°C or 36.0°C. Absorbance profiles were obtained at 280 nm in the XL-A analytical ultracentrifuge by using 12-mm-thick, aluminum-filled or carbon-filled epon centerpieces and fused silica windows. Integral sedimentation coefficient distributions, G(s*), were determined from individual scans, and differential sedimentation coefficient distributions, g(s*), were determined as described by Stafford (29) . No attempt was made to correct for the effects of diffusion. Correction of the sedimentation coefficients to standard conditions was done as described (26) .
RESULTS
Analytical Ultracentrifugation of MyoD. Equilibrium sedimentation analyses of MyoD (monomer Mr = 34,300; predicted charge, -6e) at rotor speeds below 5000 rpm (Table 1) reveals that it forms large aggregates (Mz
consisting of approximately 120 monomers. At 10,000 rpm there was no discernable fringe displacement, except at the very bottom of the cell, and no fringe displacement could be detected at 20,000 rpm. These observations indicate that the concentration of dissociated MyoD was '600 nM at 23.3°C. The aggregates are somewhat heterogeneous in size, as evidenced by the decrease in Mz with increasing rotor speed (Table 1) . It is unlikely that this decrease reflects a pressureinduced dissociation. There was no systematic concentrationdependence of Mz, precluding an examination of mass-action behavior.
Sedimentation velocity was used to examine the particle size distribution, to estimate the concentration of small oligomers ( Fig. 1) , and to determine whether or not the aggregates are stable at elevated temperatures ( Fig. 2 ). At 20°C, over 95% of the material (0.58 A280, initial concentration) is in a slightlyskewed boundary at 50 s ( Fig. 1) , again indicating that the micelles do not have a discrete upper size limit. The lack of material intermediate to the faster and slower sedimenting boundaries (Fig. 1A) indicates that any association is highly cooperative. Of the remaining 5%, only half ('0.01 A280) sedimented at 48,000 rpm, moving at about 3-4 s. The size of the 3-to 4-s material is uncertain, but it is likely to be smaller than a tetramer. On the basis of the corrected absorbance around 6S, the concentration of small oligomers is '600 nM, in accord with the earlier result (above).
The micelles are stable at 36°C, as shown in Fig. 2 . Over 67% of the material moved at -80 s*, and 30% moved at -5 s*. The well-defined plateau region above 90 s* indicates that the micelles have a discrete upper size limit at this temperature. When s* is adjusted to standard conditions, the micelles sediment at S20,w = 50, indicating that temperature has little effect on average micelle size. A higher rotor speed was used to characterize the slower sedimenting species (Fig. 2B) . The total baseline adjusted A280 is -0.04 at 10 s*. The lack of a plateau >10 s* is consistent with a reversible association between the slower sedimenting material and the micellar material. The slower boundary moves at 520,w 3.1, consistent with the sedimentation coefficient expected for a spherical monomer. The upper limit to the cmc is -3 ,uM under these conditions.
Sedimentation equilibrium analysis showed that any thermal effects on aggregation were fully reversible: MyoD incubated at 40°C for 30 min A review of the results demonstrates that MyoD exhibits micellar behavior, with extreme cooperativity, a high degree of polymerization, and a reversible equilibrium with monomer. The presence of other small oligomers of MyoD-e.g., dimer, trimer, etc.-cannot be excluded by our data, and the sum of their concentrations is reported as the cmc. Thermodynamically, it is the free monomer concentration that describes the cmc. Thus, the cmcs reported here are upper estimates.
Further evidence of micelle formation is provided by sizeexclusion chromatography (results not shown). Full-length MyoD, analyzed at a loading concentration of -175 ,u M, yields a peak at a size >660 kDa, followed by a long plateau and a second peak at about the size of a dimer or tetramer. All of the fractions, including the largest forms of MyoD, could bind specifically and at about the same specific activity to the muscle creatine kinase gene enhancer. Rechromatography of either the larger form or the smaller form of MyoD (brought to the same initial concentration) generated the same column profile. This demonstrates the reversibility of the equilibrium (31, 32 Model I describes the behavior expected for MyoD itself. Since MyoD binds to DNA as a homodimer, the model considers both dimer and micelle formation. Extension of the model to include other small oligomeric forms is straightforward. The concentration of dimers is constant and depends only on the ratio of the cmc to the dimer dissociation constant. On the other hand, the concentration of micelles depends strongly on the total concentration of MyoD. Therefore, any change that affects the cmc would have a strong effect on the dimer concentration. Such changes could occur in a number of ways-e.g., protein phosphorylation, ligand binding, etc. Any change that reduces the cmc will reduce the dimer concentration by sequestering MyoD in micelles, whereas changes that increase the cmc would mobilize large quantities of MyoD dimers. Such an effect may account for the observed stimulation of DNA binding by MyoD-E47 heterodimers in the presence of cell extracts (18) .
Because the concentration of MyoD dimer is constant, the fraction of DNA sites occupied by MyoD also is constant and dependent on the ratio of the cmc to the Kd of the dimer DNA complex (Table 2 ). This provides a simple mechanism for permitting the binding of MyoD to one site on DNA, while preventing binding at different site. Consider an example with MyoD having a cmc of 10-7 M binding nonspecifically to DNA with a Kd of 10-5 and to a specific site with a Kd of 10-9. At all concentrations of MyoD exceeding the cmc, the specific site would be 99% filled, while less than 1% of the nonspecific sites would ever fill.
The fact that MyoD forms heterodimers with other HLHcontaining proteins is taken into consideration in model II in which a second protein is included ( Table 2 ). In this model, the Table 2 , homodimer formation for the two proteins is completely independent of their heteroassociation properties due to the buffering afforded by micelles. More generally, the independence of all interactions involving smaller oligomers of either protein can be shown. Thus, micelle formation provides a simple mechanism for uncoupling interactions from one another.
In model II, the formation of heterodimer depends on the cmc for each protein but is independent of the homodimer associations and insensitive to the total concentration of either protein (Table 2) . Changes in the cmc of either protein will directly affect heterodimer formation. Again, because of the buffering properties of the micelles, the ratios of the concentrations of the various dimeric species are fixed at values specified by the cmcs and Kds. Therefore, the ratios of the species competing for binding to sites on DNA will be constant and dictated by the cmcs and Kds ( In genera"l, the degree of cooperativity will depend exponentially on the number of subunits in a complex. Therefore, model II and model III are not completely independent. Rather, they describe limits for how MyoD will behave in heteroassociating systems. In model II, the conjugate protein exhibits the same sort of highly cooperative association behavior as MyoD, whereas in model III, the conjugate protein can show little or no cooperative behavior. This leads to very different expectations concerning concentration dependence of the functions associated with these proteins.
The models described here can be extended to accommodate more proteins and more interactions. This will be needed to describe all of the suspected interactions between MyoD, the various E2A proteins, and MyoD and either Idl or Id2 (2, 5, 19, 30, 33) . Taken together, micelle formation suggests mechanisms in which combinatorial processes could be accommodated by the appropriate adjustment of cmcs and Kds for such proteins.
Earlier studies involving the bHLH domain of MyoD indicated that this region forms dimers and tetramers, but no evidence of micelle formation was observed (16, 34) . Furthermore, a single-site mutation in the loop region of MyoD-bHLH produces a peptide that exhibits micellar behavior, suggesting that fairly small changes can induce the bHLH domain to become micellar (T.M.L., M.A.S., H.W., and R.E.K., unpublished data). However, the structural changes that result in switching from a dimeric to a micellar form are unclear at this time.
The in vivo concentration of MyoD is not known. Both the observed localization of MyoD to the nucleus (15) and the nonideality due to macromolecular crowding in this environment (35) would be expected to enhance micellization. Indeed, the punctate staining of nuclei observed by immunofluorescence is consistent with MyoD micellization (15 
